Sono-enzymatically engineered tannic acid/doxycycline-lignin nanoparticles enable self-assembled bioactive chitosan hydrogels for chronic wound healing

Chronic wounds remain a major clinical challenge due to their multifactorial pathology, characterised by excessive proteolytic and oxidative enzyme activity, persistent inflammation, bacterial infection, and biofilm formation. Here, we report a green, nano-enabled hydrogel fabricated through the in situ self-assembly of thiolated chitosan (TCS), driven by tannic acid/doxycycline-functionalised lignin nanoparticles (PLD NPs). Doxycycline was incorporated at a sub-inhibitory concentration (12.5 μg/mL), enabling PLD NPs (0.5 mg/mL) to inhibit matrix metalloproteinase (MMP) activity by approximately 50% without inducing antibacterial effects. Dynamic interactions between the polymer network and NPs produced injectable, self-healing hydrogels capable of stimuli-responsive NPs release under chronic wound-like conditions, including variations in pH, hydrogen peroxide, and lysozyme. Ex vivo evaluation using human chronic wound exudates demonstrated potent inhibition of MMP and myeloperoxidase activities by 73% and 80%, respectively. The hydrogels further exhibited strong antimicrobial and antibiofilm activity against Staphylococcus aureus and Pseudomonas aeruginosa , achieving 4.8- and 4.3-log reductions in bacterial viability while preventing 73% and 65% of biofilm formation, respectively. In vitro studies confirmed excellent biocompatibility with human keratinocytes and fibroblasts, together with up to 82% cellular antioxidant activity and enhanced fibroblast migration. Importantly, in an in vivo full-thickness S. aureus -infected mouse wound model, the hydrogels achieved complete wound closure within 18 days, outperforming commercial antiseptic treatments. Overall, this work demonstrates a multifunctional hydrogel platform that simultaneously modulates the chronic wound microenvironment, controls infection and biofilm formation, reduces oxidative stress, and promotes tissue regeneration, offering a promising strategy for advanced chronic wound management.

Authors

Institutions

Publication Details

Journal
Materials Today Bio
Published
2026-10-29
DOI
https://doi.org/10.1016/j.mtbio.2026.103792
Primary Topic
Wound Healing and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sono-enzymatically engineered tannic acid/doxycycline-lignin nanoparticles enable self-assembled bioactive chitosan hydrogels for chronic wound healing

Tzanko Tzanov, Katerina S. Todorova, Eva Ramon, Dolores Hinojosa-Caballero et al.
1 links
Materials Today Bio
Wound Healing and Treatments
article

Sono-enzymatically engineered tannic acid/doxycycline-lignin nanoparticles enable self-assembled bioactive chitosan hydrogels for chronic wound healing

Tzanko Tzanov, Katerina S. Todorova, Eva Ramon, Dolores Hinojosa-Caballero, Reza Ahmadi, Zdravka Petrova
article en

Abstract

Chronic wounds remain a major clinical challenge due to their multifactorial pathology, characterised by excessive proteolytic and oxidative enzyme activity, persistent inflammation, bacterial infection, and biofilm formation. Here, we report a green, nano-enabled hydrogel fabricated through the in situ self-assembly of thiolated chitosan (TCS), driven by tannic acid/doxycycline-functionalised lignin nanoparticles (PLD NPs). Doxycycline was incorporated at a sub-inhibitory concentration (12.5 μg/mL), enabling PLD NPs (0.5 mg/mL) to inhibit matrix metalloproteinase (MMP) activity by approximately 50% without inducing antibacterial effects. Dynamic interactions between the polymer network and NPs produced injectable, self-healing hydrogels capable of stimuli-responsive NPs release under chronic wound-like conditions, including variations in pH, hydrogen peroxide, and lysozyme. Ex vivo evaluation using human chronic wound exudates demonstrated potent inhibition of MMP and myeloperoxidase activities by 73% and 80%, respectively. The hydrogels further exhibited strong antimicrobial and antibiofilm activity against Staphylococcus aureus and Pseudomonas aeruginosa , achieving 4.8- and 4.3-log reductions in bacterial viability while preventing 73% and 65% of biofilm formation, respectively. In vitro studies confirmed excellent biocompatibility with human keratinocytes and fibroblasts, together with up to 82% cellular antioxidant activity and enhanced fibroblast migration. Importantly, in an in vivo full-thickness S. aureus -infected mouse wound model, the hydrogels achieved complete wound closure within 18 days, outperforming commercial antiseptic treatments. Overall, this work demonstrates a multifunctional hydrogel platform that simultaneously modulates the chronic wound microenvironment, controls infection and biofilm formation, reduces oxidative stress, and promotes tissue regeneration, offering a promising strategy for advanced chronic wound management.

Materials Today BioVol. 41
Bulgarian Academy of Sciences (BG), Hospital Terrassa (ES), Consorci Sanitari de Terrassa (ES), Universitat Politècnica de Catalunya (ES)
Good health and well-being
Openalex Percentile: Top 17%
Wound Healing and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon